Gene · 410
Papers2,331
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,331
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A case report of multiple system atrophy-mimics: Importance of comprehensive evaluation in suspected familial cases. | Medicine (Baltimore) | 2026 | 41578513 | PubTator, text mining | PubMed |
| Assessing metal tolerance genes in enterococci isolated from animals in South Brazil. | An Acad Bras Cienc | 2026 | 41538632 | PubTator, text mining | PubMed |
| Saposin B Deficiency With Neurologic and Hepatobiliary Involvement: Two Patients Expanding the Clinical Spectrum. | J Child Neurol | 2026 | 41334784 | PubTator, text mining | PubMed |
| Spectrum of ARSA mutations in Iranian patients with metachromatic leukodystrophy. | Biochem Genet | 2026 | 39806039 | PubTator, text mining | PubMed |
| Genomic Effects of Biomechanical Loading in Adolescent Human Growth Plate Cartilage: A Pilot Study. | Cartilage | 2026 | 39655393 | PubTator, text mining | PubMed |
| WES-Based Screening of a Swedish Patient Series with Parkinson's Disease. | Genes (Basel) | 2025 | 41465155 | PubTator, text mining | PubMed |
| CRISPR-mediated genomic repair of ARSA mutations in metachromatic leukodystrophy: a transformative step toward precision neuromodulation. | Ann Med Surg (Lond) | 2025 | 41377317 | PubTator, text mining | PubMed |
| Plasma proteomic signatures of preclinical Alzheimer's disease biomarkers and memory in clinically unimpaired older adults. | medRxiv | 2025 | 41282856 | PubTator, text mining | PubMed |
| Coverage with evidence development for medicines with insufficient evidence of clinical benefit: experience from the Netherlands. | Int J Technol Assess Health Care | 2025 | 41243444 | PubTator, text mining | PubMed |
| Proteomic changes induced by acute exercise and high-intensity interval training during pregnancy: a pilot randomised controlled trial. | Sci Rep | 2025 | 41214136 | PubTator, text mining | PubMed |
| Peripheral immune cell-specific genes in Parkinson's disease uncovered by multi-omics with therapeutic implications. | NPJ Parkinsons Dis | 2025 | 41120349 | PubTator, text mining | PubMed |
| Structural Simplification from Tricyclic to Bicyclic Scaffolds: A Long-Term Investigation in the Field of Adenosine Receptor Antagonists. | Cells | 2025 | 41002445 | PubTator, text mining | PubMed |
| Nucleotide- and metalloid-driven conformational changes in the arsenite efflux ATPase ArsA. | Proc Natl Acad Sci U S A | 2025 | 40880530 | PubTator, text mining | PubMed |
| The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping. | Viruses | 2025 | 40872751 | PubTator, text mining | PubMed |
| Causal links between programmed cell death and hypertrophic scars: Integrative analysis of multi-omics Mendelian randomization and preliminary experimental validation. | Burns | 2025 | 40865488 | PubTator, text mining | PubMed |
| Distinct bacterial community structures and arsenic biotransformation gene profiles in dust. | Front Microbiol | 2025 | 40809051 | PubTator, text mining | PubMed |
| Evidence Regarding Metachromatic Leukodystrophy Newborn Screening. | Pediatrics | 2025 | 40790235 | PubTator, text mining | PubMed |
| ARSA Variants Associated With Cognitive Decline and Long-Term Preservation of Motor Function in Metachromatic Leukodystrophy. | J Inherit Metab Dis | 2025 | 40751594 | PubTator, text mining | PubMed |
| Critical analysis of translational potential of rodent models of white matter pathology across a wide spectrum of human diseases. | Cell Death Dis | 2025 | 40744926 | PubTator, text mining | PubMed |
| Metachromatic Leukodystrophy: New Therapy Advancements and Emerging Research Directions. | Neurology | 2025 | 40577679 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/410/papers?page=2